Core value dossiers for medical technologies
Essential tool to support market access and marketing efforts through the lifecycle of the product
Recent news and posts
Universal neonatal screening extended to sickle cell disease in France
On August 3, 2024, the Ministry of Labor, Health, and Solidarity published an Order in the Official Journal of the French Republic amending the Order on the organization of the national neonatal screening program using laboratory examinations. Starting November 1, 2024, all newborns will be screened for sickle cell disease. Before, this type of screening was performed only if a particular risk of developing the disease was established. Other modifications include organizational changes and modifications related to the timing of blood sample collection.
More details can be found in French here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.